ASX Releases
To access ASX releases prior to those listed below please visit the ASX Website and enter our ASX Code BTA.
2009
- Appendix 3Y: Change of Director's Interest Notice 23 December 2009
- ATO Class Ruling issued 16 December 2009
- Response to an ASX Query 15 December 2009
- S&P Announces December S&P ASX Index Rebalance 4 December 2009
- Cleansing statement 12 November 2009
- 2009 AGM Results 12 November 2009
- 2009 AGM Addresses 12 November 2009
- Return to shareholders - update 12 November 2009
- Biota acquires the antibacterial assets of MaxThera Inc 12 November 2009
- Appendix 3B - New Share Issue 12 November 2009
- Biota acquires the antibacterial assets of Prolysis Ltd 12 November 2009
- CS-8958 Phase III prevention study underway 5 November 2009
- Relenza Q1 Royalty 29 October 2009
- Change in a substantial holder 28 October 2009
- Appendix 3B: New Issue Announcement 26 October 2009
- Notice of Annual General Meeting/Example Proxy Form 30 September 2009
- Change in a substantial holder 19 August 2009
- Letter to Shareholders 19 August 2009
- Open Briefing-CEO on FY09 Results and Capital Return 19 August 2009
- Biota delivers net profit after tax of $38.2 million 19 August 2009
- 2009 Preliminary Final Report & Annual Report 19 August 2009
- Biota to return $20 million to shareholders 13 August 2009
- LANI Phase III clinical trials in Asia prove successful 10 August 2009
- RSV program returned to Biota 10 August 2009
- GSK Relenza capacity to triple 23 July 2009
- Relenza Q4 royalties $8.9 million 23 July 2009
- Ceasing to be a substantial holder 6 July 2009
- Options Lapsing 1 July 2009
- Becoming a substantial holder 11 June 2009
- HRV phase IIa study achieves clinical proof-of-concept 11 June 2009
- Ceasing to be a substantial holder 10 June 2009
- Australia adds 1.6m Relenza courses to National Stockpile 29 May 2009
- Important GSK initiatives to new influenza A (H1N1) strain 4 May 2009
- Relenza Q3 royalty $32.3m 23 April 2009
- Response to an ASX Query 22 April 2009
- Appendix 3Y: Change of Director's Interest Notice 6 April 2009
- Daiichi Sankyo exercise right to market CS-8958 in Japan 30 March 2009
- Substantial Shareholder Notice 24 March 2009
- Appendix 3Z: Final Director's Interest Notice - J Grant 2 March 2009
- Appendix 3X: Initial Director`s Interest Notice 2 March 2009
- Biota appoints new Chairman 2 March 2009
- Open Briefing - CEO on H1 Result & Outlook 18 February 2009
- Biota announces half year net profit of $7.2 million 18 February 2009
- Revised Relenza Royalty for December 2008 quarter 13 February 2009
- GSK imports additional Relenza to Japan 11 February 2009
- Relenza Royalty for December 2008 quarter 6 February 2009
- UK orders 10.6m Relenza courses 30 January 2009
